stock valuation

The Trade Desk CEO bought $148M in stock as shares fell 55%, betting growth will reaccelerate from 10% guidance despite strong fundamentals and 95%+ customer retention.

Alphabet stock doubled from 2025 lows, but whether it's cheap or expensive depends on AI execution and earning growth sustainability at current valuations.

On Holding's stock dipped on conservative 2026 guidance, but record gross margins and 20%+ revenue growth suggest significant upside potential for investors.

Bloom Energy stock has surged 600% since March 2025 on strong fuel cell demand from AI data centers, but 112x forward earnings multiples suggest much positive news is already priced in.

Tesla must submit Full Self-Driving data to NHTSA by March 9, with the regulatory outcome potentially determining the stock's 2026 trajectory amid investor skepticism.

Nvidia shares lag amid AI spending concerns despite strong earnings. March GTC conference with CEO Jensen Huang could reignite investor confidence at 21x forward earnings valuation.

Viavi CMO sells 16% of holdings as stock surges 85% YTD on 6G news. P/S ratio hits multi-year high—valuation signal suggests selling, not buying.

Lemonade trades at $53 with path to $100 via 31% premium growth, improving profitability metrics, and potential multiple expansion as it reaches sustained profitability.

Nvidia exits Arm and Applied Digital stakes, citing valuation concerns, while its $5B Intel investment doubles in two months, generating $5B unrealized gain.

Broadcom stock surged 60% amid AI boom with 96% buy ratings from Wall Street, though it's pulled back 23% from peak. Earnings due March 4.

Black Cypress Capital more than doubles Floor & Decor position with $7.51M Q4 purchase, now representing 8.57% of fund assets, signaling confidence in potential cyclical bottom.

Despite 12% sales growth and 30% EPS expansion, $AMZN stock fell 10% YTD as $200B AI infrastructure spending concerns offset cloud momentum.

Sezzle reports strong Q4 results and plans major product expansion in 2026, with stock valuation potentially underpricing future earnings growth and diversification potential.

Pfizer's reasonable valuation, robust pipeline, and 6.4% dividend yield offer disciplined returns versus speculative biotech like Regencell, whose 21,000% surge lacks fundamental justification.

Microsoft trades at attractive valuations with 17% revenue growth and 39% Azure expansion, offering potential 25% upside if P/E returns to 30x.

Red Cat Holdings shares fell 11.2% amid concerns it may pursue secondary offerings like competitor Kratos Defense to fund its $70 million annual cash burn.

Cybersecurity market expanding to $500B by 2030 as AI adoption accelerates. Palo Alto Networks positioned for growth despite recent stock decline.

Paramount Skydance wins WBD acquisition at $31/share after Netflix exits. Stock down 15% YTD despite favorable valuation metrics suggesting potential underpricing.

GE Vernova's stock surged 170% since spinoff with strong backlog growth, but its 50+ P/E ratio raises valuation concerns despite robust power division performance.

Micron stock surges 326% on AI demand with strong valuation metrics suggesting further upside potential through 2028 supply shortage.